Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Julius

Showing results (241-250 of 243) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 243 results.
Journal of the American Society of Nephrology : JASN|March 30, 2023
Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005H Ibsen, M H Olsen, K Wachtell, et al.
Journal of the American Society of Nephrology : JASN|March 30, 2023
Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005H Ibsen, M H Olsen, K Wachtell, et al.
Journal of Human Hypertension|April 23, 2004
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE studyH M Reims, S E Kjeldsen, W E Brady, et al.
Pageof 25

Showing results (241-250 of 243) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 243 results.
Journal of the American Society of Nephrology : JASN|March 30, 2023
Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005H Ibsen, M H Olsen, K Wachtell, et al.
Journal of the American Society of Nephrology : JASN|March 30, 2023
Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005H Ibsen, M H Olsen, K Wachtell, et al.
Journal of Human Hypertension|April 23, 2004
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE studyH M Reims, S E Kjeldsen, W E Brady, et al.
Pageof 25